BioPathNet: A New AI Tool for Analyzing Biomedical Data Networks
BioPathNet is an AI tool for analyzing biomedical data networks, aiding in gene functions and disease mechanisms. 🧬🔍
March 19, 2026
Follow us
latest articles
Discover the newest research about AI innovations in 🤖 Machine Learning.
Leveraging Digital Technology and Artificial Intelligence to Describe the Real-World Belgian Chronic Lymphocytic Leukemia Patient Population: The BE-CLLEAR Study.
AI in CLL Research: 586 Patients Analyzed, 29.7% Started Treatment, 42.8% TP53 Aberrations. 📊💉
March 19, 2026
DiaCardia: AI Model for ECG-Based Prediabetes Detection
DiaCardia: An AI model detects prediabetes through ECG data, enabling non-invasive screening with wearable devices. 🩺📈
March 18, 2026
Safety and user perception of general-purpose large language models in pediatric healthcare: Evaluations of ChatGPT by doctors and parents.
Evaluating ChatGPT in Pediatric Healthcare: 73.2% accuracy, 80% parent clarity rating. Caution advised! 🤖👶📊
March 18, 2026
Investigating Placebos and Controls Used in Large Language Model-Based Chatbot Intervention Trials: Protocol for a Methodological Review.
Exploring LLM Chatbot Trials: Control Conditions Matter! 🤖📊
March 18, 2026
Artificial Intelligence-enhanced Electrocardiography for Heart Failure Screening and Risk Stratification.
AI in ECG: Revolutionizing heart failure screening & risk stratification. Key findings from Dhingra et al. 📈❤️
March 18, 2026
Artificial intelligence-based volumetric measurements for longitudinal clinical assessment of treatment response in high-grade gliomas: Validation across institutional and public datasets.
AI in High-Grade Glioma Treatment: 1648 MRI Sequences Analyzed, 15s Segmentation Time, Moderate Agreement with MDTB Diagnoses 📊🧠
March 17, 2026
An Integrated Risk Prediction Model for Gout Using Clinical Data, Ultrasound Features, and Deep Learning: A Retrospective Multicenter Study.
Innovative gout risk model combines clinical data, ultrasound, and deep learning, achieving AUC of 0.904! 📊🦵
March 17, 2026
Personalizing fall fear prevention in knee osteoarthritis: an interpretable prediction framework via IGKSO synchronous optimization and SHAP-based risk stratification.
Personalized fall fear prediction in knee osteoarthritis: 541 patients, 0.8842 F1 score, 0.9451 AUC. Key risk factors identified! 📊👩⚕️
March 16, 2026
Localizing the epileptogenic zone using deep learning and neuroimaging: A systematic review.
Deep learning enhances epileptogenic zone localization in drug-resistant epilepsy, yet bias and clinical applicability remain concerns. 📊🧠
March 16, 2026